1. The Constitutionality of Medicare Drug-Price Negotiation under the Takings Clause.
- Author
-
Bhargava, Raj, Brown, Nathan, Kapczynski, Amy, Kesselheim, Aaron S., Lim, Stephanie Y., and Morten, Christopher J.
- Subjects
COST control ,INSURANCE ,MEDICARE ,NEGOTIATION ,MEDICAL care ,HEALTH policy ,PHARMACEUTICAL industry ,ECONOMICS ,FEDERAL government ,DRUGS ,PHARMACEUTICAL services insurance ,BUDGET ,MEDICAL care costs ,GOVERNMENT regulation - Abstract
In recent months, pharmaceutical manufacturers have brought legal challenges to a provision of the 2022 Inflation Reduction Act (IRA) empowering the federal government to negotiate the prices Medicare pays for certain prescription medications. One key argument made in these filings is that price negotiation is a "taking" of property and violates the Takings Clause of the US Constitution. Through original case law and health policy analysis, we show that government price negotiation and even price regulation of goods and services, including patented goods, are constitutional under the Takings Clause. Finding that the IRA violates the Takings Clause would radically upend settled constitutional law and jeopardize the US's most important state and federal health care programs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF